Stuart M. Langbein
Partner
Washington, D.C.
Languages
English
Practice Group
Regulatory
Stuart Langbein brings a passion for healthcare to his office each day. He is renowned for his leadership in facilitating the market viability of new medical technologies, and knows how to develop and implement strategies that secure their coverage, coding, and reimbursement.
When clients work with Stuart, they quickly learn about the importance of being proactive. That's especially critical for organizations with new medical technologies; Stuart is often advising them long before they're granted Food and Drug Administration approval.
Stuart routinely works with a cross-section of medical technology organizations, including pharmaceutical, biological, and medical device companies; trade associations, and academic medical centers. He continues to build on his prior experience at the Centers for Medicare & Medicaid Services, as well as on his long-term relationships with many agency officials.
Stuart is a longstanding volunteer for the JDRF, an international organization focused on a cure for diabetes. He coordinates the Hogan Lovells Walk to Cure Diabetes team, and works on national government advocacy issues related to diabetes.
Industries
Areas of focus
Representative experience
Latest thinking and events
Health Alert
Slow but Steady: CMS Proposes to Simplify and Slow Down the Quality Payment Program Rollout
Health AlertHealth Alert
Draft Senate Health Bill Finally Revealed – Vote Could Take Place as Early as Next Week
Hogan LovellsHealth Alert
CMS request for information presents rare opportunity for medicare stakeholder engagement
Health AlertHogan Lovells Publications
First Steps: Trump Administration's Initial Executive Actions Target the Affordable Care Act and Obama Administration's Midnight Regulations
Health AlertHogan Lovells Publications
Rolling Back the Clock – What the New Administration and Congress Can Do to Halt or Delay the Obama Administration's Midnight Regulations
Health AlertView More
